Yanai, Hidekatsu, et al. “Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 Diabetes”. Journal of Clinical Medicine Research, vol. 17, no. 9, Oct. 2025, pp. 469-8, https://doi.org/10.14740/jocmr6370.